Bio-Techne Corp ROE 2006-2020 | TECH

Current and historical return on equity (ROE) values for Bio-Techne Corp (TECH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Bio-Techne Corp ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-06-30 $0.23B $1.38B 17.72%
2020-03-31 $0.19B $1.29B 15.02%
2019-12-31 $0.20B $1.32B 16.22%
2019-09-30 $0.09B $1.17B 8.12%
2019-06-30 $0.10B $1.17B 8.50%
2019-03-31 $0.12B $1.15B 11.02%
2018-12-31 $0.10B $1.10B 8.94%
2018-09-30 $0.13B $1.11B 12.06%
2018-06-30 $0.13B $1.08B 12.41%
2018-03-31 $0.11B $1.06B 11.40%
2017-12-31 $0.12B $1.00B 12.05%
2017-09-30 $0.07B $0.96B 7.87%
2017-06-30 $0.08B $0.95B 8.34%
2017-03-31 $0.07B $0.91B 8.28%
2016-12-31 $0.08B $0.89B 9.32%
2016-09-30 $0.10B $0.90B 11.60%
2016-06-30 $0.11B $0.88B 12.26%
2016-03-31 $0.11B $0.85B 12.37%
2015-12-31 $0.10B $0.86B 11.78%
2015-09-30 $0.11B $0.84B 12.75%
2015-06-30 $0.11B $0.85B 13.04%
2015-03-31 $0.11B $0.82B 13.38%
2014-12-31 $0.12B $0.82B 14.56%
2014-09-30 $0.11B $0.79B 13.87%
2014-06-30 $0.11B $0.80B 14.57%
2014-03-31 $0.11B $0.78B 14.98%
2013-12-31 $0.11B $0.75B 15.41%
2013-09-30 $0.11B $0.73B 15.69%
2013-06-30 $0.11B $0.74B 15.81%
2013-03-31 $0.11B $0.72B 16.03%
2012-12-31 $0.11B $0.70B 16.33%
2012-09-30 $0.11B $0.68B 17.10%
2012-06-30 $0.11B $0.67B 18.04%
2012-03-31 $0.11B $0.64B 18.87%
2011-12-31 $0.11B $0.60B 19.32%
2011-09-30 $0.11B $0.59B 19.97%
2011-06-30 $0.11B $0.59B 20.20%
2011-03-31 $0.11B $0.57B 20.62%
2010-12-31 $0.11B $0.54B 21.45%
2010-09-30 $0.11B $0.52B 21.62%
2010-06-30 $0.11B $0.50B 22.40%
2010-03-31 $0.11B $0.50B 22.73%
2009-12-31 $0.11B $0.49B 22.79%
2009-09-30 $0.10B $0.47B 23.45%
2009-06-30 $0.11B $0.46B 23.67%
2009-03-31 $0.11B $0.43B 23.71%
2008-12-31 $0.11B $0.42B 23.62%
2008-09-30 $0.11B $0.49B 23.02%
2008-06-30 $0.10B $0.49B 22.02%
2008-03-31 $0.10B $0.47B 21.74%
2007-12-31 $0.09B $0.47B 21.09%
2007-09-30 $0.09B $0.47B 20.94%
2007-06-30 $0.09B $0.44B 21.55%
2007-03-31 $0.08B $0.41B 21.90%
2006-12-31 $0.08B $0.39B 22.24%
2006-09-30 $0.08B $0.36B 23.35%
2006-06-30 $0.07B $0.34B 23.68%
2006-03-31 $0.07B $0.32B 25.15%
2005-12-31 $0.07B $0.28B 26.03%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.858B $0.739B
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $139.879B 10.77
Amgen (AMGN) United States $139.495B 15.15
CSL (CSLLY) Australia $90.737B 0.00
Gilead Sciences (GILD) United States $85.893B 12.37
Vertex Pharmaceuticals (VRTX) United States $69.995B 39.06
Regeneron Pharmaceuticals (REGN) United States $66.917B 24.75
Illumina (ILMN) United States $51.942B 59.99
Biogen (BIIB) United States $47.535B 8.13
Moderna (MRNA) United States $28.414B 0.00
Seattle Genetics (SGEN) United States $27.439B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.605B 0.00
Genmab (GMAB) Denmark $23.557B 19.38
Alexion Pharmaceuticals (ALXN) United States $22.329B 9.30
Genmab (GNMSF) Denmark $21.977B 65.25
BioMarin Pharmaceutical (BMRN) United States $21.445B 155.59
Incyte (INCY) United States $20.628B 0.00
BeiGene (BGNE) Cayman Islands $18.710B 0.00
BioNTech SE (BNTX) Germany $16.732B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.070B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.658B 36.64
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Exact Sciences (EXAS) United States $12.757B 0.00
Sarepta Therapeutics (SRPT) United States $12.482B 0.00
Galapagos (GLPG) Belgium $11.942B 43.27
ARGENX SE-ADR (ARGX) Netherlands $10.728B 0.00
QIAGEN (QGEN) Netherlands $10.579B 26.85
Novavax (NVAX) United States $10.346B 0.00
Immunomedics (IMMU) United States $9.458B 0.00
Guardant Health (GH) United States $8.543B 0.00
Repligen (RGEN) United States $7.760B 123.18
Ascendis Pharma (ASND) Denmark $7.571B 0.00
Emergent Biosolutions (EBS) United States $6.890B 27.29
Exelixis (EXEL) United States $6.714B 24.42
ACADIA Pharmaceuticals (ACAD) United States $6.511B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.370B 197.33
Vir Biotechnology (VIR) United States $6.272B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.177B 15.37
Mirati Therapeutics (MRTX) United States $5.825B 0.00
Acceleron Pharma (XLRN) United States $5.727B 0.00
MyoKardia (MYOK) United States $5.548B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.159B 0.00
Adaptive Biotechnologies (ADPT) United States $4.822B 0.00
Zai Lab (ZLAB) China $4.628B 0.00
Sorrento Therapeutics (SRNE) United States $4.555B 0.00
Bluebird Bio (BLUE) United States $4.355B 0.00
NeoGenomics (NEO) United States $4.344B 1311.33
China Biologic Products (CBPO) China $4.174B 23.20
Blueprint Medicines (BPMC) United States $4.163B 0.00
MorphoSys AG (MOR) Germany $4.053B 53.12
Amicus Therapeutics (FOLD) United States $3.924B 0.00
Halozyme Therapeutics (HALO) United States $3.890B 0.00
Global Blood Therapeutics (GBT) United States $3.740B 0.00
Arena Pharmaceuticals (ARNA) United States $3.694B 0.00
Denali Therapeutics (DNLI) United States $3.560B 0.00
Reata Pharmaceuticals (RETA) United States $3.470B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.360B 0.00
Fate Therapeutics (FATE) United States $3.126B 0.00
Insmed (INSM) United States $3.067B 0.00
Inovio Pharmaceuticals (INO) United States $3.002B 0.00
Alkermes (ALKS) Ireland $2.954B 61.92
Principia Biopharma (PRNB) United States $2.812B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.699B 0.00
Amarin (AMRN) Ireland $2.695B 0.00
Twist Bioscience (TWST) United States $2.449B 0.00
Mesoblast (MESO) Australia $2.035B 0.00
Editas Medicine (EDIT) United States $1.961B 0.00
Viela Bio (VIE) United States $1.916B 0.00
Ligand Pharmaceuticals (LGND) United States $1.908B 64.49
PHARMA MAR SA (PHMMF) Spain $1.866B 0.00
UniQure (QURE) Netherlands $1.838B 0.00
Sangamo Therapeutics (SGMO) United States $1.760B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.740B 0.00
Seres Therapeutics (MCRB) United States $1.731B 0.00
I-Mab (IMAB) China $1.683B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
Revance Therapeutics (RVNC) United States $1.663B 0.00
Eidos Therapeutics (EIDX) United States $1.655B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.532B 0.00
Adverum Biotechnologies (ADVM) United States $1.502B 0.00
Zealand Pharma (ZEAL) Denmark $1.430B 0.00
Zymeworks (ZYME) Canada $1.408B 0.00
Mersana Therapeutics (MRSN) United States $1.374B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.365B 0.00
Coherus BioSciences (CHRS) United States $1.340B 7.81
NGM Biopharmaceuticals (NGM) United States $1.304B 0.00
Intra-Cellular Therapies (ITCI) United States $1.293B 0.00
Epizyme (EPZM) United States $1.290B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Cytokineticsorporated (CYTK) United States $1.268B 0.00
REGENXBIO (RGNX) United States $1.266B 0.00
Beam Therapeutics (BEAM) United States $1.241B 0.00
NantKwest (NK) United States $1.217B 0.00
Alcobra (ARCT) United States $1.214B 0.00
Intellia Therapeutics (NTLA) United States $1.199B 0.00
Akcea Therapeutics (AKCA) United States $1.182B 0.00
Alector (ALEC) United States $1.148B 0.00
Arvinas (ARVN) United States $1.144B 0.00
Compugen (CGEN) Israel $1.121B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.077B 0.00
Arcus Biosciences (RCUS) United States $1.057B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.036B 0.00
Retrophin (RTRX) United States $0.975B 0.00
Heska (HSKA) United States $0.962B 0.00
VBI Vaccines (VBIV) United States $0.958B 0.00
Athenex (ATNX) United States $0.950B 0.00
Myriad Genetics (MYGN) United States $0.915B 47.19
Intrexon (PGEN) United States $0.882B 0.00
Dynavax Technologies (DVAX) United States $0.853B 0.00
Morphic Holding (MORF) United States $0.852B 0.00
Pharming Group (PHGUF) Netherlands $0.851B 19.43
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Cara Therapeutics (CARA) United States $0.806B 0.00
Codexis (CDXS) United States $0.782B 0.00
Cellectis S.A (CLLS) France $0.743B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.728B 0.00
Vericel (VCEL) United States $0.723B 0.00
Castle Biosciences (CSTL) United States $0.715B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.711B 0.00
Frequency Therapeutics (FREQ) United States $0.700B 0.00
MiMedx (MDXG) United States $0.674B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.652B 5.71
Sinovac Biotech (SVA) China $0.640B 20.87
Agenus (AGEN) United States $0.622B 0.00
Cue Biopharma (CUE) United States $0.599B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.587B 0.00
Syros Pharmaceuticals (SYRS) United States $0.572B 0.00
UROGEN PHARMA (URGN) United States $0.552B 0.00
MeiraGTx Holdings (MGTX) United States $0.524B 0.00
Kala Pharmaceuticals (KALA) United States $0.519B 0.00
Athersys (ATHX) United States $0.509B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
Protagonist Therapeutics (PTGX) United States $0.495B 0.00
Anika Therapeutics (ANIK) United States $0.491B 21.46
AnaptysBio (ANAB) United States $0.482B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.478B 0.00
Innate Pharma S.A (IPHA) France $0.471B 0.00
BioDelivery Sciences (BDSI) United States $0.463B 32.79
Aquinox Pharmaceuticals (NLTX) United States $0.461B 0.00
Cel-Sci (CVM) United States $0.453B 0.00
AC Immune SA (ACIU) Switzerland $0.453B 0.00
Prometic Life Sciences (LMNL) Canada $0.439B 0.00
IBio (IBIO) United States $0.437B 0.00
Scholar Rock Holding (SRRK) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.426B 0.00
Puma Biotechnology (PBYI) United States $0.418B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 9.61
Albireo Pharma (ALBO) United States $0.400B 0.00
Clovis Oncology (CLVS) United States $0.396B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Kamada (KMDA) Israel $0.383B 15.93
Merus (MRUS) Netherlands $0.383B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.370B 0.00
MannKind (MNKD) United States $0.364B 0.00
PDL BioPharma (PDLI) United States $0.362B 0.00
Precision BioSciences (DTIL) United States $0.355B 0.00
CytomX Therapeutics (CTMX) United States $0.352B 0.00
WAVE Life Sciences (WVE) Singapore $0.337B 0.00
Trevena (TRVN) United States $0.335B 0.00
Geron (GERN) United States $0.333B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Biofrontera AG (BFRA) Germany $0.297B 0.00
OSMOTICA PHARM (OSMT) United States $0.296B 0.00
Arbutus Biopharma (ABUS) United States $0.296B 0.00
Affimed (AFMD) Germany $0.294B 0.00
Starpharma Holdings (SPHRY) Australia $0.291B 0.00
Selecta Biosciences (SELB) United States $0.290B 0.00
Cellular Biomedicine (CBMG) United States $0.290B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.289B 0.00
Spero Therapeutics (SPRO) United States $0.279B 0.00
Menlo Therapeutics (MNLO) United States $0.277B 0.00
NextCure (NXTC) United States $0.276B 0.00
Fortress Biotech (FBIO) United States $0.274B 0.00
Pfenex (PFNX) United States $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
DBV Technologies S.A (DBVT) France $0.256B 0.00
Northwest Biotherapeutics (NWBO) United States $0.255B 0.00
Abeona Therapeutics (ABEO) United States $0.250B 0.00
Dyadic (DYAI) United States $0.245B 0.00
Celldex Therapeutics (CLDX) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.241B 0.00
Verastem (VSTM) United States $0.241B 0.00
IVERIC Bio (ISEE) United States $0.233B 0.00
Pluristem Therapeutics (PSTI) Israel $0.229B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.226B 0.00
Strongbridge Biopharma (SBBP) United States $0.223B 0.00
Cerecor (CERC) United States $0.214B 0.00
Exicure (XCUR) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.207B 9.65
Theratechnologies (THTX) Canada $0.199B 0.00
Sutro Biopharma (STRO) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Aptinyx (APTX) United States $0.187B 0.00
XOMA (XOMA) United States $0.186B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Liquidia Technologies (LQDA) United States $0.168B 0.00
Cyclerion Therapeutics (CYCN) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Eton Pharmaceuticals (ETON) United States $0.164B 0.00
Cidara Therapeutics (CDTX) United States $0.164B 0.00
Bellus Health (BLU) Canada $0.161B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
TELA Bio (TELA) United States $0.153B 0.00
Applied Genetic Technologies (AGTC) United States $0.152B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Gritstone Oncology (GRTS) United States $0.140B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.139B 0.00
Celyad SA (CYAD) Belgium $0.138B 0.00
Palatin Technologies (PTN) United States $0.133B 3.40
Cardiff Oncology (CRDF) United States $0.129B 0.00
Lumos Pharma (LUMO) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 6.45
Oncobiologics (OTLK) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.122B 0.00
Windtree Therapeutics (WINT) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Checkpoint Therapeutics (CKPT) United States $0.118B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.112B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.096B 0.00
Vaccinex (VCNX) United States $0.095B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
AnPac Bio-Medical Science (ANPC) China $0.090B 0.00
Organovo Holdings (ONVO) United States $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.085B 0.00
Unum Therapeutics (UMRX) United States $0.082B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Edesa Biotech (EDSA) Canada $0.074B 0.00
Proteostasis Therapeutics (PTI) United States $0.074B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Catalyst Biosciences (CBIO) United States $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 97.50
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Soligenix (SNGX) United States $0.067B 0.00
Signal Genetics (MGEN) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
IMMURON (IMRN) Australia $0.062B 0.00
Happiness Biotech Group (HAPP) China $0.059B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
Curis (CRIS) United States $0.049B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Novogen (KZIA) Australia $0.043B 0.00
Spherix (AIKI) United States $0.043B 0.00
Cesca Therapeutics (THMO) United States $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
AmpliPhi Biosciences (ARMP) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.036B 0.00
OvaScience (MLND) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Forte Biosciences (FBRX) United States $0.035B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.033B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Chanticleer Holdings (SONN) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
AEterna Zentaris (AEZS) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00